RT Journal Article SR Electronic T1 Analysis of internet trends related to medications for COVID-19 in ten countries with the highest number of cases JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.08.20190785 DO 10.1101/2020.09.08.20190785 A1 Josimar E. Chire Saire A1 Roselyn Lemus-Martin YR 2020 UL http://medrxiv.org/content/early/2020/09/27/2020.09.08.20190785.abstract AB During the last months, the pandemic generated by coronavirus SARS-CoV-2 moved governments, research groups and health organizations to plan, test and execute health policies. At the beginning, the treatment was not clear but in the next months, research groups have conducted studies to recommend or ban some medicines. At the same time, countries with most cases were changing from Asia, Europe to America. Different treatments and medications have been tested and recommended in many countries, such as Hydroxycloroquine, Ivermectin, Azithromycin, Dexamethasone, Prednisone, Remdesivir. This paper is a preliminary study about which medications people are searching on the Internet, considering ten countries with most cases in the world such as Chile, Spain, United Kingdom, Brazil, United States, India, Russia, South Africa, Peru and Mexico.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo applicableAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data can be obtained using the parameters detailed in the paper.